# Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH

> **NCT05043181** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Tang-Du Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Familial Hypercholesterolemia

## Interventions

- **BIOLOGICAL:** Low Density Lipoprotein Receptor mRNA Exosomes

## Key facts

- **NCT ID:** NCT05043181
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-12
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05043181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05043181, "Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05043181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*